A+ A A-

What's New

New to Portal

ASM Updates

News Digest

Public Policy

Upcoming Events

Career Connections


Featured Content

  • FDA Approves Cresemba To Treat Fungal Infections

    FDA Approves Cresemba To Treat Fungal Infections

    The FDA has approved isavuconazonium sulfate (Cresemba, Astellas Pharma), a new antifungal drug, for the treatment of adults with invasive aspergillosis and invasive mucormycosis, rare but serious infections in immunocompromised patients.

  • NIH Funds Nine Antimicrobial Resistance Diagnostics Projects

    NIH Funds Nine Antimicrobial Resistance Diagnostics Projects

    ​The National Institute of Allergy and Infectious Diseases has awarded more than $11 million in first-year funding for nine research projects supporting enhanced diagnostics to rapidly detect antimicrobial-resistant bacteria.

  • ASM Microbe 2016

    ASM Microbe 2016

    Call for sessions, courses, and workshops is now open through May 19, 2015! Submit your ideas today to contribute directly to the success of this unmatched event!

  • Bugs as Drugs Report

    Bugs as Drugs Report

    The American Academy of Microbiology releases new report titled “Harnessing the Power of Microbes as Therapeutics: Bugs as Drugs”


topics 10072014 qa 10072014 cumitechs 10072014 

Advertisement

American Society For Microbiology © 2015 | Privacy Policy | Terms of Use